Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psilocybin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06943573
What this trial is testing

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

Who this might be right for
Bipolar II Depression
Lakshmi N Yatham 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07565909
What this trial is testing

Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression

Who this might be right for
DepressionAnxiety
University of Washington 72
Not applicableStudy completedNCT06650800
What this trial is testing

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression

Who this might be right for
Depressive DisorderDepressive Disorder, Treatment-ResistantHallucinogens+1 more
Centre Hospitalier Universitaire de Nīmes 10
Early research (Phase 1)Study completedNCT06258031
What this trial is testing

PsilOCD: A Pharmacological-Challenge Feasibility Study

Who this might be right for
Obsessive-Compulsive Disorder
Imperial College London 19
Not applicableLooking for participantsNCT06368492
What this trial is testing

The Impact of Psilocybin on Pain in Fibromyalgia Patients

Who this might be right for
Fibromyalgia
Maastricht University 35
Early research (Phase 1)Study completedNCT02950467
What this trial is testing

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

Who this might be right for
DistressDepressionGrief
Joshua Woolley 30
Testing effectiveness (Phase 2)Looking for participantsNCT06386003
What this trial is testing

Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

Who this might be right for
Post Traumatic Stress DisorderPTSDChronic PTSD
Unity Health Toronto 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04620759
What this trial is testing

Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder

Who this might be right for
Major Depressive DisorderAlcohol Use Disorder
Johns Hopkins University 90
Very early researchLooking for participantsNCT06656702
What this trial is testing

Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Johns Hopkins University 24
Not applicableEnrolling By InvitationNCT07737990
What this trial is testing

Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression

Who this might be right for
Treatment-resistant Depression (TRD)
Joshua Rosenblat 65
Early research (Phase 1)Ended earlyNCT05322954
What this trial is testing

Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

Who this might be right for
Methamphetamine Use DisorderSubstance-Related DisordersChemically-Induced Disorders+2 more
University of Wisconsin, Madison 5
Testing effectiveness (Phase 2)Looking for participantsNCT05995769
What this trial is testing

Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder

Who this might be right for
Alcohol Use DisorderAlcoholism
University of Calgary 128
Not applicableActive Not RecruitingNCT07189988
What this trial is testing

Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism

Who this might be right for
Alcohol Use Disorder
Healing Advocacy Fund 20
Testing effectiveness (Phase 2)Looking for participantsNCT06706232
What this trial is testing

Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality

Who this might be right for
Bipolar II DisorderDepression, BipolarSuicidality
The University of Texas Health Science Center, Houston 10
Early research (Phase 1)Study completedNCT06884514
What this trial is testing

Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756736
What this trial is testing

Psilocybin Therapy for Methamphetamine Use Disorder and HIV

Who this might be right for
Methamphetamine Use DisorderHuman Immunodeficiency Virus (HIV)
Nicky Mehtani, MD, MPH 30
Testing effectiveness (Phase 2)UnknownNCT05243329
What this trial is testing

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

Who this might be right for
Treatment Resistant DisordersPost Traumatic Stress Disorder
Halucenex Life Sciences Inc. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06378229
What this trial is testing

Psilocybin for Hospitalized Patients with Treatment-resistant Depression

Who this might be right for
Treatment Resistant Depression
University Hospital, Ghent 100
Very early researchStudy completedNCT04501653
What this trial is testing

Precision Functional Brain Mapping in Psilocybin

Who this might be right for
Psilocybin
Washington University School of Medicine 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05351541
What this trial is testing

Psilocybin Therapy for Chronic Low Back Pain

Who this might be right for
Chronic Low-back Pain
Joshua Woolley, MD, PhD 30
Next Page